Actively Recruiting
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
Led by Shanghai Zhongshan Hospital · Updated on 2025-05-14
5600
Participants Needed
13
Research Sites
210 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Effects and Safety of Diabetic GUideline Algorithm Implementation in the Community (GUARD-Community) study is a 2-arm, cluster-randomized control trial to evaluate the effect and safety of guideline algorithm intervention performed by primary care physicians on cardiovascular and renal outcomes in elderly patients with high risk in community.
CONDITIONS
Official Title
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males or females aged 65 and above (≥65) receiving treatment from a local community health service center
- Diagnosed with type 2 diabetes according to ADA criteria, confirmed by repeated blood sugar tests
- Complicated with chronic kidney disease and/or very high/high cardiovascular risk, including ASCVD, target organ damage, or multiple major risk factors
- Diabetes duration of 10 years or more with traditional cardiovascular risk factors
You will not qualify if you...
- Pregnant women or women planning to become pregnant
- Estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73m2
- Patients who cannot be followed up for 36 months due to health condition or migration
- Unwilling or unable to sign informed consent
- Diagnosis of type 1 diabetes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 13 locations
1
Xiangcheng Second People's Hospital
Suzhou, Jaingsu, China, 215501
Actively Recruiting
2
Caohu Community Healthcare Center
Suzhou, Jiangsu, China, 215006
Actively Recruiting
3
Huangqiao Community Healthcare Center
Suzhou, Jiangsu, China, 215006
Actively Recruiting
4
Xiangcheng People's Hospital.
Suzhou, Jiangsu, China, 215131
Actively Recruiting
5
Yuanhe Community Healthcare Center
Suzhou, Jiangsu, China, 215131
Actively Recruiting
6
Xiangcheng Third People's Hospital
Suzhou, Jiangsu, China, 215134
Actively Recruiting
7
Taiping Community Healthcare Center
Suzhou, Jiangsu, China, 215137
Actively Recruiting
8
Yangchenghu People's Hospital
Suzhou, Jiangsu, China, 215138
Actively Recruiting
9
Health Center of Xiangcheng Tourism Resort
Suzhou, Jiangsu, China, 215141
Actively Recruiting
10
Caohu People's Hospital
Suzhou, Jiangsu, China, 215144
Actively Recruiting
11
Dongqiao Community Healthcare Center
Suzhou, Jiangsu, China, 215152
Actively Recruiting
12
Xiangcheng Traditional Chinese Medicine Hospital
Suzhou, Jiangsu, China, 215155
Actively Recruiting
13
Chengyang Community Healthcare Center
Suzhou, Jiangsu, China
Actively Recruiting
Research Team
X
Xiaoying Li, MD
CONTACT
X
Xiaomu Li, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here